Judy Chou
Director/Board Member at AKERO THERAPEUTICS, INC.
Net worth: - $ as of 2024-03-30
Profile
Judy Chou is the President, Chief Executive Officer & Director of Altrubio, Inc. and an Independent Director at Akero Therapeutics, Inc. She was previously the Director & Member-Governors Board at BIOCOM and the Senior Vice President & Global Head-Biotech at Bayer Pharmaceuticals.
Chou holds a doctorate degree from Yale University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AKERO THERAPEUTICS, INC.
-.--% | 2023-04-05 | 0 ( -.--% ) | - $ | 2024-03-30 |
Judy Chou active positions
| Companies | Position | Start |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Director/Board Member | 2021-07-11 |
Altrubio, Inc.
 Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Chief Executive Officer | - |
Former positions of Judy Chou
| Companies | Position | End |
|---|---|---|
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Director/Board Member | 2020-11-18 |
Bayer Pharmaceuticals
 Bayer Pharmaceuticals Pharmaceuticals: MajorHealth Technology Bayer Pharmaceuticals operates as a German pharmaceuticals company. The private company is based in Leverkusen, Germany. | Corporate Officer/Principal | - |
Training of Judy Chou
| Yale University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AKERO THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Commercial Services |
Altrubio, Inc.
Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Retail Trade |
Bayer Pharmaceuticals
Bayer Pharmaceuticals Pharmaceuticals: MajorHealth Technology Bayer Pharmaceuticals operates as a German pharmaceuticals company. The private company is based in Leverkusen, Germany. | Health Technology |
- Stock Market
- Insiders
- Judy Chou
